Digital Insurance spoke with Nancy Clark, assistant vice president of regulatory strategy at Verisk, and a leader of the firm's Regulatory Data Exchange (RDeX) tool, about what the service offers to ...

University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...

It's true Oura partners with Palantir Technologies, a software company that serves the U.S. government. But some claims about ...

SOUTH BEND — The St. Joseph County Council voted against a proposed data center on 1,057 acres near New Carlisle, a project that has garnered staunch support and opposition from officials and ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.

DexCom, incorporated in Delaware and headquartered in San Diego, California, designs, manufactures, and markets continuous glucose monitoring (CGM) systems to help individuals with types 1 and 2 ...

The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...